Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity

J Clin Oncol. 2007 Sep 1;25(25):4028-9. doi: 10.1200/JCO.2007.13.5251. Epub 2007 Jul 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Calcium / administration & dosage*
  • Clinical Trials, Phase III as Topic
  • Colorectal Neoplasms / drug therapy*
  • Drug Interactions
  • Humans
  • Magnesium / administration & dosage*
  • Neurotoxicity Syndromes / etiology
  • Neurotoxicity Syndromes / prevention & control*
  • Organoplatinum Compounds / adverse effects*
  • Oxaliplatin
  • Research Design
  • Treatment Outcome

Substances

  • Organoplatinum Compounds
  • Oxaliplatin
  • Magnesium
  • Calcium